REFERENCES
  1. Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus disease 2019 – associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J Am Heart Assoc . Feb 2021; 10(3):e019650.
  2. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 May 14;41(19):1798-1800.
  3. Dominguez-Erquicia P, Dobarro D, Raposeiras-Roubín S, Bastos-Fernandez G, Iñiguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur Heart J. 2020 Jun 07;41(22):2132.
  4. Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art review. J Am Coll Cardiol. June 2020;75(23):2950-73.
  5. O’Gara  PT, Kushner  FG, Ascheim  DD,  et al.  2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.  Circulation . 2013;127(4):362-425.
  6. Ibanez  B, James  S, Agewall  S,  et al; ESC Scientific Document Group.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).  Eur Heart J . 2018;39(2):119-177.
  7. Lattuca B, Bouziri N, Kerneis, et al. Antithrombotic therapy for patients with left ventricular mural thrombus. J Am Coll Cardiol . 2020;75:1676-1685.
  8. Dalia, T., Lahan, S., Ranka, S, et al.  Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis. Thrombosis J . 2021l 19:7. https://doi.org/10.1186/s12959-021-00259-w
  9. Jeon HD, Patel J, Priester T, Moten M. Left ventricular thrombus caused by COVID-19: how long to treat? J Am Coll Cardiol . May 2021; 77 (18_Supplement_1) 2013.
  10. Sonaglioni A, Albini A, Nicolosi GL, et al. Case report: an unusual case of biventricular thrombosis in a COVID-19 patient With ischemic dilated cardiomyopathy: assessment of mass mobility and embolic risk by tissue doppler imaging. Front Cardiovasc Med . 2021 Jul 29;8:694542.